|Andrew M. Kiselica, PhD
210 Mizzou North
To improve early detection and treatment of Alzheimer’s disease and related dementias
The primary focus of the ClEaR-ADRD lab is to develop and validate tools to detect the earliest signs of cognitive decline associated with neurodegenerative diseases, such as Alzheimer’s. Currently, we are also involved in collaborations to better understand the relationship between stress and cognitive aging. Furthermore, we participate in research to evaluate the ability of novel technologies (e.g., smartphone applications) to improve day-to-day functioning among older adults experiencing cognitive declines. We collaborate with other researchers at the University of Missouri, the University of Texas—Austin, and the University of South Florida. The lab welcomes MU undergraduates, recruits PhD students through our Rehabilitation Science program, and works with psychology interns and fellows through the MU Department of Health Psychology’s training programs.
Current Grant Funding
Dr. Kiselica is currently the PI on an Alzheimer’s Association Research Fellowship (2019-AARF-641693): Towards a Rigorous Biological and Clinical Definition of Alzheimer’s. The goal of this series of studies is to apply advanced neuropsychological techniques to better define the stages of the Alzheimer’s Continuum.
Past Grant Funding
Dr. Kiselica was the PI on a National Academy of Neuropsychology Clinical Research Grant (2019-2020): Reaffirming Neuropsychology’s Central Role in Understanding Alzheimer’s Disease in the Age of Biomarkers. This grant supported research to develop and validate advanced neuropsychological techniques for detecting the earliest signs of cognitive decline associated with neurodegenerative diseases.